The U.S. Food and Drug Administration (FDA) informed the company that an expanded access protocol for NVG-291 may proceed This news release constitutes a "designated news release" for the purposes of ...

Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the 12 months ended December 31, 2024, and provides updates on its antiviral product pipeline, ...

With its new mobile crushing and screening plants and its SPECTIVE operating concept, Kleemann is presenting innovations from its extensive product portfolio. The new scalping screen MOBISCREEN MSS ...